$ARIA News Six stocks to watch 4:27 p.m. Feb. 26
Post# of 72711
Posted On: 03/11/2014 12:54:33 PM
$ARIA News
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
ARIAD Pharmaceuticals' CEO Presents at Cowen and Company 34th Annual Health Care Conference (Transcript) 2:01 p.m. March 4, 2014 - Seeking Alpha
10-K: ARIAD PHARMACEUTICALS INC 5:15 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals (ARIA): Today's Pre-Market Leader Stock 8:19 a.m. Feb. 28, 2014 - TheStreet.com
Ariad on the move on Iclusig partnership chatter 3:45 p.m. Feb. 27, 2014 - Seeking Alpha
Should You Worry About the Short Interest in Ariad Pharmaceuticals (ARIA)? - Tale of the Tape 10:04 a.m. Feb. 27, 2014 - Zacks.com
Roundtable Top Picks for the Week of Feb. 24th - Video Blog 4:31 p.m. Feb. 26, 2014 - Zacks.com
ARIAD's Q4 Loss Narrower-Than-Expected - Analyst Blog 2:30 p.m. Feb. 26, 2014 - Zacks.com
Benzinga's Top Downgrades 7:23 a.m. Feb. 26, 2014 - benzinga.com
Ariad Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript 11:17 a.m. Feb. 25, 2014 - Seeking Alpha
Top Trending Tickers On StockTwits For February 25 10:12 a.m. Feb. 25, 2014 - benzinga.com
5 Biotech Stocks That Are Buyout Candidates 3:48 a.m. Feb. 25, 2014 - InvestorPlace.com
Earnings Scheduled For February 25, 2014 3:28 a.m. Feb. 25, 2014 - benzinga.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Feb. 24, 2014 - TheStreet.com
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success 8:49 a.m. Feb. 24, 2014 - Seeking Alpha
Ariad gives activist investor a board seat, plans to add another 11:47 a.m. Feb. 21, 2014 - Seeking Alpha
Ariad Pharmaceuticals (ARIA) Strong In Pre-Market Trading 9:43 a.m. Feb. 21, 2014 - TheStreet.com
New positions from top healthcare stockpickers 3:51 p.m. Feb. 19, 2014 - Seeking Alpha
An Overview Of Ariad Pharmaceuticals 10:22 a.m. Feb. 19, 2014 - Seeking Alpha
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Rises 10.2% - Tale of the Tape 9:25 a.m. Feb. 19, 2014 - Zacks.com
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. Today - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference 7:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Feb. 21, 2014 - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
ARIAD to Present at the Leerink Swann Global Healthcare Conference 7:35 a.m. Feb. 5, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
ARIAD Pharmaceuticals' CEO Presents at Cowen and Company 34th Annual Health Care Conference (Transcript) 2:01 p.m. March 4, 2014 - Seeking Alpha
10-K: ARIAD PHARMACEUTICALS INC 5:15 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals (ARIA): Today's Pre-Market Leader Stock 8:19 a.m. Feb. 28, 2014 - TheStreet.com
Ariad on the move on Iclusig partnership chatter 3:45 p.m. Feb. 27, 2014 - Seeking Alpha
Should You Worry About the Short Interest in Ariad Pharmaceuticals (ARIA)? - Tale of the Tape 10:04 a.m. Feb. 27, 2014 - Zacks.com
Roundtable Top Picks for the Week of Feb. 24th - Video Blog 4:31 p.m. Feb. 26, 2014 - Zacks.com
ARIAD's Q4 Loss Narrower-Than-Expected - Analyst Blog 2:30 p.m. Feb. 26, 2014 - Zacks.com
Benzinga's Top Downgrades 7:23 a.m. Feb. 26, 2014 - benzinga.com
Ariad Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript 11:17 a.m. Feb. 25, 2014 - Seeking Alpha
Top Trending Tickers On StockTwits For February 25 10:12 a.m. Feb. 25, 2014 - benzinga.com
5 Biotech Stocks That Are Buyout Candidates 3:48 a.m. Feb. 25, 2014 - InvestorPlace.com
Earnings Scheduled For February 25, 2014 3:28 a.m. Feb. 25, 2014 - benzinga.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Feb. 24, 2014 - TheStreet.com
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success 8:49 a.m. Feb. 24, 2014 - Seeking Alpha
Ariad gives activist investor a board seat, plans to add another 11:47 a.m. Feb. 21, 2014 - Seeking Alpha
Ariad Pharmaceuticals (ARIA) Strong In Pre-Market Trading 9:43 a.m. Feb. 21, 2014 - TheStreet.com
New positions from top healthcare stockpickers 3:51 p.m. Feb. 19, 2014 - Seeking Alpha
An Overview Of Ariad Pharmaceuticals 10:22 a.m. Feb. 19, 2014 - Seeking Alpha
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Rises 10.2% - Tale of the Tape 9:25 a.m. Feb. 19, 2014 - Zacks.com
Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone 10:12 a.m. Today - PR Newswire - PRF
New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara 7:24 a.m. March 5, 2014 - PR Newswire - PRF
Workday Upgraded to $150 a Share; Ariad Pharmaceuticals Q4 Loss Widens 12:34 a.m. Feb. 28, 2014 - ACCESSWIRE
ARIAD Reports 2013 Financial Results and Outlines Key Objectives for 2014 7:35 a.m. Feb. 25, 2014 - BusinessWire - BZX
ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference 7:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
ARIAD Expands Its Board of Directors with Appointment of Alexander J. Denner, Ph.D. of Sarissa Capital Management 7:35 a.m. Feb. 21, 2014 - BusinessWire - BZX
Facebook to Buy Messaging App WhatsApp; Garmin Ltd. Hits New 1-year High on Earnings 12:29 a.m. Feb. 20, 2014 - ACCESSWIRE
ARIAD to Present at the RBC Capital Markets Healthcare Conference 7:35 a.m. Feb. 19, 2014 - BusinessWire - BZX
ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014 7:35 a.m. Feb. 10, 2014 - BusinessWire - BZX
TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Feb. 6, 2014 - ACCESSWIRE
ARIAD to Present at the Leerink Swann Global Healthcare Conference 7:35 a.m. Feb. 5, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
(0)
(0)Scroll down for more posts ▼